Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TC-325 (Hemospray) vs Standard of Care in Malignant GI Bleeding
NCT02135627Completed
- Sponsor
- McGill University Health Centre
- Start
- Apr 2014
- Primary completion
- Jul 2016
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Randomised, open-label trial of Hemospray in Gastrointestinal Bleeding (GIB) (2 arms), sponsored by McGill University Health Centre. Primary endpoint: Hemostasis at 3 minutes. Started Apr 2014; status: completed.
02
Drugs
Hemospray
03
Conditions
Gastrointestinal Bleeding (GIB)
Beyond the preview
Go deeper on NCT02135627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135627.